TickerGuard
Buy Day today: Neutral (60) Mixed market breadth · no major macro event
ABSI

Absci Corp

Healthcare · Biotechnology

10.70$ +9.1% vs. previous close Closing price · As of: Sep 22, 2026

Statements

Balance Sheet

All figures as a percentage of total assets in the same period.

Tick rows to compare them in a chart (up to 4)

Balance Sheet ABSI
Line item 2019 2020 2021 2022 2023 2024 2025
100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0%
70.1% 82.7% 64.1% 58.2% 55.5% 62.7% 69.2%
67.2% 78.9% 59.3% 18.7% 33.3% 19.3% 9.3%
67.2% 78.9% 59.3% 51.2% 44.9% 52.6% 66.7%
1.1% 1.8% 0.3% 0.5% 1.0% 0.0%
0.0% 0.0% 2.5% 4.7%
25.7% 15.1% 13.8% 18.1%
0.0% 5.0% 6.6% 0.0%
1.5% 0.2% 12.9% 16.1% 22.2% 21.0% 19.2%
311.4% 24.3% 14.1% 14.5% 18.9% 16.1% 12.4%
17.8% 11.4% 7.9% 9.4% 13.6% 13.4% 10.5%
9.7% 4.3% 1.6% 2.2% 2.6% 2.1% 1.2%
1.4% 2.4% 2.0% 0.8% 0.7% 1.7% 1.3%
9.0% 4.7% 0.3% 2.5% 2.1% 0.6%
-211.4% 75.7% 85.9% 85.5% 81.1% 83.9% 87.6%
-212.5% -101.7% -44.8% -92.2% -187.1% -238.6% -288.9%
473.8% 104.2% 21.7% 28.3% 42.4% 51.6% 63.2%

Data as of: September 22, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?